| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |